Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 9.10.2025Zentiva k.s. (ZNT-3)4858BAripiprazole Zentiva 10 mg tablety (tbl 28x10 mg (blis.OPA/Al/PVC/Al))9.10.2025O
 9.10.2025BB Pharma a.s. (BBP-CZ-1)88709ANALGIN inj (sol inj 5x5 ml (amp.skl.hnedá))15.10.2025R
 9.10.2025Egis Pharmaceuticals PLC (EGI)6790AMemigmin 10 mg (tbl flm 56x10 mg (blis.PVC/PE/PVDC/Al))30.10.2025Z
 9.10.2025G.L. Pharma GmbH (GLH-2)0822EPazopanib G.L. Pharma 200 mg filmom obalené tablety (tbl flm 90x200 mg (blis.Al/PVC/PE/PVDC))10.10.2025R
 9.10.2025G.L. Pharma GmbH (GLH-2)5360DMelkart Duo 50 mg/1000 mg filmom obalené tablety (tbl flm 60x50 mg/1000 mg (blis.Al/OPA/Al/PVC))8.10.2025R
 9.10.2025G.L. Pharma GmbH (GLH-2)92041Petinimid cps (cps 100x250 mg (blis.PVC/Al))14.10.2025O
 9.10.2025Menarini International Operations Luxembourg S.A. (MNR)4721COmarit 10 mg orodispergovateľné tablety (tbl oro 30x10 mg (blis.OPA/Al/PVC/Al))9.10.2025O
 9.10.2025Johnson & Johnson, s.r.o. (JHN-SK-1)97607RISPERDAL CONSTA 50 mg prášok a disperzné prostredie na injekčnú suspenziu s predĺženým uvoľňovaním (plu igf 1x50 mg+1x solv.(liek.inj.skl.+liek.inj.+adaptér na liekovku))1.11.2025R
 9.10.2025Johnson & Johnson, s.r.o. (JHN-SK-1)97606RISPERDAL CONSTA 37,5 mg prášok a disperzné prostredie na injekčnú suspenziu s predĺženým uvoľňovaním (plu igf 1x37,5 mg+1x solv.(liek.inj.skl.+liek.inj.+adaptér na liekovku))15.11.2025R
 9.10.2025AstraZeneca AB (AZC)6746ETRUQAP 200 mg filmom obalené tablety (tbl flm 64(4x16)x200 mg (blis.Al/Al))2.10.2025U
 8.10.2025TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)8598DPaliperidón Teva 150 mg injekčná suspenzia s predĺženým uvoľňovaním (sus ijp 1x150 mg (striek.inj.napln.+2x ihla))8.10.2025O
 8.10.2025CHEPLAPHARM Arzneimittel GmbH (CEP-1)43540Seroquel XR 200 mg (tbl plg 60(6x10)x200 mg (blis.PCTFE/PVC/Al))8.10.2025R
 8.10.2025KRKA, d.d., Novo mesto (KRK-2)3538CAdolax 20 mg/10 mg (tbl plg 60x1x20 mg/10 mg (blis.PVC/PVDC/PET/Al-jednotliv.bal.))6.10.2025O
 8.10.2025KRKA, d.d., Novo mesto (KRK-2)44043Kventiax 300 mg (tbl flm 60x300 mg (blis.PVC/Al))9.10.2025R
 8.10.2025KRKA, d.d., Novo mesto (KRK-2)30405Dasselta 5 mg filmom obalená tableta (tbl flm 100x5 mg (blis.OPA/Al/PVC/Al))6.10.2025O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)